At the end of the Stanford Biomedical Engineering Society Spring Industry Panel, Dr. Eric Schuur told me, “You get a head-start hearing these things when you are young.” Indeed, over the past hour—a discussion panel organized by BMES Industry Vice President Alex Maben and BMES Industry Officer Amelia Traylor—three speakers from biotechnological and biocomputational companies voiced insights on essential undergraduate skills, post-undergrad education, and workplace culture.
Emeritus Professor Bill Durham is a legend in Human Biology. A former graduate of Stanford, Bill has been with the Human Biology Program since 1977, where he has carried out research on environmental anthropology, the challenges of sustainable development, and conservation issues in Galapagos. But perhaps the most surprising moment of his career came in 2001 when a friend called Bill about a rare ailment that had just been discovered in his family.
Biochemist and neurobiologist Michael Lin is developing smart biological therapies that may finally provide the “magic bullet” for cancer. He sat down with Probe Magazine to discuss his dreams and current research projects, and give a few words of advice to STEM students.
Gail Wight is an American artist whose work combines art with biology, neurology and technology. Her work explores the impact of life sciences on the human being. She is a professor in Art Practice and has been teaching art at Stanford since 2003.
Short for “clustered regularly interspaced short palindromic repeats”, CRISPR is a DNA-based system that allows the user to have unparalleled control and precision in genome editing. CRISPR applications are constantly being refined as new research, particularly from Stanford, helps increase our understanding of this system.